advertisement

List of abstracts related to

Listed by Classification

9.4.1 Steroid-induced glaucoma (1106 abstracts found)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Kowal TJ
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

94674 Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Sbardella D
International journal of molecular sciences 2021; 22: (IGR: 22-2)

94813 Incidence of steroid response in microinvasive glaucoma surgery with trabecular microbypass stent and ab interno trabeculectomy
Abtahi M
Canadian Journal of Ophthalmology 2022; 57: 167-174 (IGR: 22-2)

94674 Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Sbardella D
International journal of molecular sciences 2021; 22: (IGR: 22-2)

94659 Case Report: Steroid-induced Ocular Hypertension in a 6-year-old Boy
Tasaki A
Optometry and Vision Science 2021; 98: 867-869 (IGR: 22-2)

94704 Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma
Zhou Y
Canadian Journal of Ophthalmology 2022; 57: 277-283 (IGR: 22-2)

94968 Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
Menet J
Lupus 2021; 0: 9612033211033988 (IGR: 22-2)

94782 Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma
AlObaida I
European Journal of Ophthalmology 2021; 0: 11206721211023310 (IGR: 22-2)

94704 Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma
Pruet CM
Canadian Journal of Ophthalmology 2022; 57: 277-283 (IGR: 22-2)

94782 Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma
Al Owaifeer AM
European Journal of Ophthalmology 2021; 0: 11206721211023310 (IGR: 22-2)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Prosseda PP
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

94968 Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
Agrinier N
Lupus 2021; 0: 9612033211033988 (IGR: 22-2)

94813 Incidence of steroid response in microinvasive glaucoma surgery with trabecular microbypass stent and ab interno trabeculectomy
Rudnisky CJ
Canadian Journal of Ophthalmology 2022; 57: 167-174 (IGR: 22-2)

94674 Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Tundo GR
International journal of molecular sciences 2021; 22: (IGR: 22-2)

94968 Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
Dufrost V
Lupus 2021; 0: 9612033211033988 (IGR: 22-2)

94813 Incidence of steroid response in microinvasive glaucoma surgery with trabecular microbypass stent and ab interno trabeculectomy
Nazarali S
Canadian Journal of Ophthalmology 2022; 57: 167-174 (IGR: 22-2)

94782 Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma
Alotaibi H
European Journal of Ophthalmology 2021; 0: 11206721211023310 (IGR: 22-2)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Ning K
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

94674 Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Coletta M
International journal of molecular sciences 2021; 22: (IGR: 22-2)

94704 Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma
Fang C
Canadian Journal of Ophthalmology 2022; 57: 277-283 (IGR: 22-2)

94674 Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Manni G
International journal of molecular sciences 2021; 22: (IGR: 22-2)

94813 Incidence of steroid response in microinvasive glaucoma surgery with trabecular microbypass stent and ab interno trabeculectomy
Damji KF
Canadian Journal of Ophthalmology 2022; 57: 167-174 (IGR: 22-2)

94704 Selective laser trabeculoplasty in steroid-induced and uveitic glaucoma
Khanna CL
Canadian Journal of Ophthalmology 2022; 57: 277-283 (IGR: 22-2)

94782 Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma
Alsafi A
European Journal of Ophthalmology 2021; 0: 11206721211023310 (IGR: 22-2)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Wang B
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

94968 Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
Conart JB
Lupus 2021; 0: 9612033211033988 (IGR: 22-2)

94674 Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
Oddone F
International journal of molecular sciences 2021; 22: (IGR: 22-2)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Alvarado J
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

94782 Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma
Ali Aljasim L
European Journal of Ophthalmology 2021; 0: 11206721211023310 (IGR: 22-2)

94968 Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
Wahl D; Duprez KA
Lupus 2021; 0: 9612033211033988 (IGR: 22-2)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Sendayen BE
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

94968 Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
Zuily S
Lupus 2021; 0: 9612033211033988 (IGR: 22-2)

94585 Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
Jabbehdari S; Stamer WD; Hu Y; Sun Y
Translational vision science & technology 2021; 10: 10 (IGR: 22-2)

91956 Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma
Bojikian KD
Journal of Glaucoma 2021; 30: e159-e163 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Ishii M
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Marzouki HZ
Cureus 2021; 13: e13146 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Sugali CK
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Cassidy PS
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Choi W
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

92363 Ab-Externo Implantation of XEN Gel Stent for Refractory Steroid-Induced Glaucoma After Lamellar Keratoplasty
Tan SY
Cureus 2021; 13: e13320 (IGR: 22-1)

92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Roddy GW
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Horita N
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Bae HW
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Chowdhury UR
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kelly RA
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Rayana NP
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92363 Ab-Externo Implantation of XEN Gel Stent for Refractory Steroid-Induced Glaucoma After Lamellar Keratoplasty
Md Din N
Cureus 2021; 13: e13320 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
AlThomali RK
Cureus 2021; 13: e13146 (IGR: 22-1)

91956 Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma
Nobrega P
Journal of Glaucoma 2021; 30: e159-e163 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Shin HJ
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Dai J
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92363 Ab-Externo Implantation of XEN Gel Stent for Refractory Steroid-Induced Glaucoma After Lamellar Keratoplasty
Mohd Khialdin S
Cureus 2021; 13: e13320 (IGR: 22-1)

92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Monson KJ
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)

91956 Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma
Roldan A
Journal of Glaucoma 2021; 30: e159-e163 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Takeuchi M
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Hefni L
Cureus 2021; 13: e13146 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Reina-Torres E
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Kim EW
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Peng M
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Matsumoto H
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92363 Ab-Externo Implantation of XEN Gel Stent for Refractory Steroid-Induced Glaucoma After Lamellar Keratoplasty
Wan Abdul Halim WH
Cureus 2021; 13: e13320 (IGR: 22-1)

91956 Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma
Forrest SL
Journal of Glaucoma 2021; 30: e159-e163 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Almarzouki N
Cureus 2021; 13: e13146 (IGR: 22-1)

92476 Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension
Fautsch MP
Current Eye Research 2021; 0: 1-6 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Sherwood JM
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

91956 Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma
Tsukikawa M
Journal of Glaucoma 2021; 30: e159-e163 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Alhejaili F
Cureus 2021; 13: e13146 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Kim CY
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

92363 Ab-Externo Implantation of XEN Gel Stent for Refractory Steroid-Induced Glaucoma After Lamellar Keratoplasty
Tang SF
Cureus 2021; 13: e13320 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Ebina-Shibuya R
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Harris SL
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries MM
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Merdad M
Cureus 2021; 13: e13146 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Hara Y
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Webber HC
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kiang AS
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Kim M
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

91956 Incidence of and Risk Factors for Steroid Response After Cataract Surgery in Patients With and Without Glaucoma
Chen PP
Journal of Glaucoma 2021; 30: e159-e163 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Liu S
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Zawawi F
Cureus 2021; 13: e13146 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Farrar GJ
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92769 Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Seong GJ
British Journal of Ophthalmology 2022; 106: 1150-1156 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Kobayashi N
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Dixon SG
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92724 Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
Alkhatib T
Cureus 2021; 13: e13146 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
O'Brien C
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Mizuki N
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Campbell M
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92429 Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies
Kaneko T
Allergy, asthma & immunology research 2021; 13: 435-449 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Parekh PH; Martin EA
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Stamer WD; Overby DR
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Cantor LB; Fellman RL
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries P; O'Callaghan J
Molecular therapy. Methods & clinical development 2021; 20: 86-94 (IGR: 22-1)

92757 The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork
Godfrey DG; Butler MR; Emanuel ME; Grover DS; Smith OU; Clark AF; Raghunathan VK; Mao W
American Journal of Pathology 2021; 191: 1020-1035 (IGR: 22-1)

90951 Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty
Vu PQ
Journal of Glaucoma 2020; 29: 1120-1125 (IGR: 21-4)

91458 Increased Hydrostatic Pressure Promotes Primary M1 Reaction and Secondary M2 Polarization in Macrophages
Wang B
Frontiers in immunology 2020; 11: 573955 (IGR: 21-4)

90951 Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty
Aggarwal S
Journal of Glaucoma 2020; 29: 1120-1125 (IGR: 21-4)

91458 Increased Hydrostatic Pressure Promotes Primary M1 Reaction and Secondary M2 Polarization in Macrophages
Kasper M
Frontiers in immunology 2020; 11: 573955 (IGR: 21-4)

90951 Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty
Lu Y
Journal of Glaucoma 2020; 29: 1120-1125 (IGR: 21-4)

91458 Increased Hydrostatic Pressure Promotes Primary M1 Reaction and Secondary M2 Polarization in Macrophages
Laffer B; Meyer Zu Hörste G
Frontiers in immunology 2020; 11: 573955 (IGR: 21-4)

90951 Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty
Xie K
Journal of Glaucoma 2020; 29: 1120-1125 (IGR: 21-4)

91458 Increased Hydrostatic Pressure Promotes Primary M1 Reaction and Secondary M2 Polarization in Macrophages
Wasmuth S
Frontiers in immunology 2020; 11: 573955 (IGR: 21-4)

90951 Comparison of Intraocular Pressure, Usage of Topical Steroids, Need for Intraocular Pressure Lowering Drops, and Incidence of Glaucoma Surgery Up to 2 Years After Penetrating Keratoplasty and Endothelial Keratoplasty
Wade M; Bhatt A
Journal of Glaucoma 2020; 29: 1120-1125 (IGR: 21-4)

91458 Increased Hydrostatic Pressure Promotes Primary M1 Reaction and Secondary M2 Polarization in Macrophages
Busch M; Jalilvand TV; Thanos S; Heiligenhaus A; Bauer D; Heinz C
Frontiers in immunology 2020; 11: 573955 (IGR: 21-4)

89966 Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
Futakuchi A
Scientific reports 2020; 10: 10308 (IGR: 21-3)

90330 Risk factors for ocular hypertension after intravitreal dexamethasone implantation in diabetic macular edema
Choi MY
Scientific reports 2020; 10: 13736 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Zhu X
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

90304 Risk of intraocular pressure elevation after topical steroids in children and adults: A systematic review
Musleh MG
European Journal of Ophthalmology 2020; 30: 856-866 (IGR: 21-3)

90741 Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants
Cao JL
Journal of Glaucoma 2020; 29: 789-793 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Suda K
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

90361 Open angle glaucoma secondary to endogenous cortisone due to pituitary microadenoma in a young patient, a case report
Kudsieh B
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 353-356 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Kempen JH
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

89966 Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
Morimoto T
Scientific reports 2020; 10: 10308 (IGR: 21-3)

90741 Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants
Srivastava SK
Journal of Glaucoma 2020; 29: 789-793 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Akagi T
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

90361 Open angle glaucoma secondary to endogenous cortisone due to pituitary microadenoma in a young patient, a case report
Casado López de la Franca E
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 353-356 (IGR: 21-3)

90330 Risk factors for ocular hypertension after intravitreal dexamethasone implantation in diabetic macular edema
Kwon JW
Scientific reports 2020; 10: 13736 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Wu S
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

90304 Risk of intraocular pressure elevation after topical steroids in children and adults: A systematic review
Bokre D
European Journal of Ophthalmology 2020; 30: 856-866 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Van Natta ML
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90361 Open angle glaucoma secondary to endogenous cortisone due to pituitary microadenoma in a young patient, a case report
Díez Gómez MA
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 353-356 (IGR: 21-3)

89966 Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
Ikeda Y
Scientific reports 2020; 10: 10308 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Friedman DS
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Ikeda HO
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Zeng W
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

90741 Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants
Lowder CY
Journal of Glaucoma 2020; 29: 789-793 (IGR: 21-3)

90304 Risk of intraocular pressure elevation after topical steroids in children and adults: A systematic review
Dahlmann-Noor AH
European Journal of Ophthalmology 2020; 30: 856-866 (IGR: 21-3)

90741 Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants
Sharma S
Journal of Glaucoma 2020; 29: 789-793 (IGR: 21-3)

90361 Open angle glaucoma secondary to endogenous cortisone due to pituitary microadenoma in a young patient, a case report
Ruiz Moreno JM
Archivos de la Sociedad Española de Oftalmologia 2020; 95: 353-356 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Altaweel MM
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Chen X
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Kameda T
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

89966 Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
Tanihara H
Scientific reports 2020; 10: 10308 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Hasegawa T
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Zheng T
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Ansari H
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90741 Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants
Baynes K
Journal of Glaucoma 2020; 29: 789-793 (IGR: 21-3)

89966 Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
Inoue T
Scientific reports 2020; 10: 10308 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Miyake M
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

89966 Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study

Scientific reports 2020; 10: 10308 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Dunn JP
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Ren J
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

90741 Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants
Eisengart J
Journal of Glaucoma 2020; 29: 789-793 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Elner SG
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90624 Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
Ke M
Frontiers in pharmacology 2020; 11: 1006 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Kido A; Nakano E
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Holbrook JT; Lim LL
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

90315 Atopic dermatitis as a risk factor for severe visual field loss in youth-a retrospective cohort study of glaucoma under steroid treatment
Tsujikawa A
Graefe's Archive for Clinical and Experimental Ophthalmology 2021; 259: 129-136 (IGR: 21-3)

89945 Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy
Sugar EA; Jabs DA;
American Journal of Ophthalmology 2020; 219: 303-316 (IGR: 21-3)

86184 Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Roberti G
Survey of Ophthalmology 2020; 65: 458-472 (IGR: 21-2)

86202 Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population
Choi W; Bae HW
British Journal of Ophthalmology 2020; 104: 1423-1429 (IGR: 21-2)

86184 Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Oddone F
Survey of Ophthalmology 2020; 65: 458-472 (IGR: 21-2)

86202 Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population
Choi EY
British Journal of Ophthalmology 2020; 104: 1423-1429 (IGR: 21-2)

86184 Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Agnifili L; Katsanos A
Survey of Ophthalmology 2020; 65: 458-472 (IGR: 21-2)

86202 Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population
Kim EW
British Journal of Ophthalmology 2020; 104: 1423-1429 (IGR: 21-2)

86184 Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Michelessi M; Mastropasqua L
Survey of Ophthalmology 2020; 65: 458-472 (IGR: 21-2)

86202 Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population
Kim CY; Kim M
British Journal of Ophthalmology 2020; 104: 1423-1429 (IGR: 21-2)

86184 Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Quaranta L
Survey of Ophthalmology 2020; 65: 458-472 (IGR: 21-2)

86202 Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population
Seong GJ
British Journal of Ophthalmology 2020; 104: 1423-1429 (IGR: 21-2)

86184 Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Riva I; Tanga L; Manni G
Survey of Ophthalmology 2020; 65: 458-472 (IGR: 21-2)

84519 Hypotony maculopathy: a surgeon's nightmare
Sen S
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 21-1)

84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
McKay KM
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)

84602 Endogenous hypercortisolism inducing reversible ocular hypertension
Griffin S
American journal of ophthalmology case reports 2019; 16: 100573 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Monsellato R
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

84314 Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation
Raj A
Cornea 2020; 39: 45-51 (IGR: 21-1)

84867 Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis
Xiao J
Ocular Immunology and Inflammation 2020; 0: 1-5 (IGR: 21-1)

84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Borkar DS
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)

84867 Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis
Zhao C
Ocular Immunology and Inflammation 2020; 0: 1-5 (IGR: 21-1)

84314 Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation
Salvador-Culla B
Cornea 2020; 39: 45-51 (IGR: 21-1)

84519 Hypotony maculopathy: a surgeon's nightmare
Parija S
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 21-1)

84602 Endogenous hypercortisolism inducing reversible ocular hypertension
Boyce T
American journal of ophthalmology case reports 2019; 16: 100573 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Trovato E
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

84314 Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation
Anwar H
Cornea 2020; 39: 45-51 (IGR: 21-1)

84519 Hypotony maculopathy: a surgeon's nightmare
Nayak B
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 21-1)

84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Sevgi DD
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)

84602 Endogenous hypercortisolism inducing reversible ocular hypertension
Edmunds B
American journal of ophthalmology case reports 2019; 16: 100573 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Turchetti P
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

84867 Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis
Liang A
Ocular Immunology and Inflammation 2020; 0: 1-5 (IGR: 21-1)

84602 Endogenous hypercortisolism inducing reversible ocular hypertension
Hills W
American journal of ophthalmology case reports 2019; 16: 100573 (IGR: 21-1)

84314 Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation
Sykakis E
Cornea 2020; 39: 45-51 (IGR: 21-1)

84867 Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis
Zhang M
Ocular Immunology and Inflammation 2020; 0: 1-5 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Forestiere M
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Susarla G
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Pistone A
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

84867 Efficacy and Safety of High-Energy Selective Laser Trabeculoplasty for Steroid-Induced Glaucoma in Patients with Quiescent Uveitis
Cheng G
Ocular Immunology and Inflammation 2020; 0: 1-5 (IGR: 21-1)

84602 Endogenous hypercortisolism inducing reversible ocular hypertension
Grafe M
American journal of ophthalmology case reports 2019; 16: 100573 (IGR: 21-1)

84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Papaliodis GN
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)

84314 Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation
Figueiredo MS
Cornea 2020; 39: 45-51 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
De Sio S
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

84314 Long-term Outcomes on de novo Ocular Hypertensive Response to Topical Corticosteroids After Corneal Transplantation
Figueiredo FC
Cornea 2020; 39: 45-51 (IGR: 21-1)

84602 Endogenous hypercortisolism inducing reversible ocular hypertension
Tehrani S
American journal of ophthalmology case reports 2019; 16: 100573 (IGR: 21-1)

84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Sobrin L
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)

84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Accetta L; Pacella F
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)

82471 Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group
Sen P
Indian Journal of Ophthalmology 2019; 67: 1650-1655 (IGR: 20-4)

82007 Gonioscopy-assisted Transluminal Trabebeculotomy in a Pediatric Patient with Steroid-induced Glaucoma
Hopen ML
Journal of Glaucoma 2019; 0: (IGR: 20-4)

82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Salimi A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420 (IGR: 20-4)

82300 Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study
Prasad D
Journal of Glaucoma 2019; 28: 929-933 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Sugiyama M
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

82079 Identification of Gene Changes Induced by Dexamethasone in the Anterior Segment of the Human Eye Using Bioinformatics Analysis
Zhang Y
Medical Science Monitor 2019; 25: 5501-5509 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Bogarin T
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82537 Gonioscopy-assisted Transluminal Trabeculotomy in a Pediatric Patient With Steroid-induced Glaucoma
Hopen ML
Journal of Glaucoma 2019; 28: e156-e158 (IGR: 20-4)

81591 Effect of Topical Periocular Steroid Use on Intraocular Pressure: A Retrospective Analysis
Maeng MM
Ophthalmic Plastic and Reconstructive Surgery 2019; 35: 465-468 (IGR: 20-4)

82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Salimi A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420 (IGR: 20-4)

82232 Retinal Defects Three Months After Intravitreal Dexamethasone Implant
Farber NC
Ophthalmic surgery, lasers & imaging retina 2019; 50: e211-e214 (IGR: 20-4)

82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Salimi A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420 (IGR: 20-4)

81923 Gonioscopy-assisted Transluminal Trabeculotomy (GATT) is An Effective Procedure for Steroid-induced Glaucoma
Boese EA
Journal of Glaucoma 2019; 28: 803-807 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Zeng W
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

81591 Effect of Topical Periocular Steroid Use on Intraocular Pressure: A Retrospective Analysis
De Moraes CG
Ophthalmic Plastic and Reconstructive Surgery 2019; 35: 465-468 (IGR: 20-4)

81923 Gonioscopy-assisted Transluminal Trabeculotomy (GATT) is An Effective Procedure for Steroid-induced Glaucoma
Shah M
Journal of Glaucoma 2019; 28: 803-807 (IGR: 20-4)

82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Winter A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420 (IGR: 20-4)

82471 Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group
Jain S
Indian Journal of Ophthalmology 2019; 67: 1650-1655 (IGR: 20-4)

82007 Gonioscopy-assisted Transluminal Trabebeculotomy in a Pediatric Patient with Steroid-induced Glaucoma
Gallardo MJ
Journal of Glaucoma 2019; 0: (IGR: 20-4)

82300 Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study
Poddar U
Journal of Glaucoma 2019; 28: 929-933 (IGR: 20-4)

82079 Identification of Gene Changes Induced by Dexamethasone in the Anterior Segment of the Human Eye Using Bioinformatics Analysis
Yang A
Medical Science Monitor 2019; 25: 5501-5509 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Wang W
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

82537 Gonioscopy-assisted Transluminal Trabeculotomy in a Pediatric Patient With Steroid-induced Glaucoma
Gallardo MJ
Journal of Glaucoma 2019; 28: e156-e158 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Saraswathy S
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Terashita Y
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

82232 Retinal Defects Three Months After Intravitreal Dexamethasone Implant
Ulrich JN
Ophthalmic surgery, lasers & imaging retina 2019; 50: e211-e214 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Hara K
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Wu S
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

81591 Effect of Topical Periocular Steroid Use on Intraocular Pressure: A Retrospective Analysis
Winn BJ
Ophthalmic Plastic and Reconstructive Surgery 2019; 35: 465-468 (IGR: 20-4)

82471 Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group
Mohan A
Indian Journal of Ophthalmology 2019; 67: 1650-1655 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Akiyama G
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82007 Gonioscopy-assisted Transluminal Trabebeculotomy in a Pediatric Patient with Steroid-induced Glaucoma
Grover D
Journal of Glaucoma 2019; 0: (IGR: 20-4)

82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Li C
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420 (IGR: 20-4)

82300 Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study
Kanaujia V
Journal of Glaucoma 2019; 28: 929-933 (IGR: 20-4)

82079 Identification of Gene Changes Induced by Dexamethasone in the Anterior Segment of the Human Eye Using Bioinformatics Analysis
Huang J
Medical Science Monitor 2019; 25: 5501-5509 (IGR: 20-4)

82537 Gonioscopy-assisted Transluminal Trabeculotomy in a Pediatric Patient With Steroid-induced Glaucoma
Grover D
Journal of Glaucoma 2019; 28: e156-e158 (IGR: 20-4)

82471 Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group
Shah C
Indian Journal of Ophthalmology 2019; 67: 1650-1655 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Xie X
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Cho Y
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

81591 Effect of Topical Periocular Steroid Use on Intraocular Pressure: A Retrospective Analysis
Glass LRD
Ophthalmic Plastic and Reconstructive Surgery 2019; 35: 465-468 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Zhu X
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

82300 Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study
Yachha SK
Journal of Glaucoma 2019; 28: 929-933 (IGR: 20-4)

82142 Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery
Harasymowycz P; Saheb H
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 413-420 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Zheng T
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

82471 Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group
Sen A
Indian Journal of Ophthalmology 2019; 67: 1650-1655 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Iguchi A
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Weinreb RN
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82300 Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study
Srivastava A
Journal of Glaucoma 2019; 28: 929-933 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Chen X
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Zheng J
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Chin S
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

82471 Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group
Jain E
Indian Journal of Ophthalmology 2019; 67: 1650-1655 (IGR: 20-4)

82292 Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Huang AS
Experimental Eye Research 2019; 187: 107774 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Ren J
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

82362 Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies
Manabe A
Pediatric Blood and Cancer 2019; 66: e27977 (IGR: 20-4)

82252 Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model
Gong Y; Ke M
Current Eye Research 2020; 45: 190-198 (IGR: 20-4)

81137 Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis
Beverstock A
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Marcus AJ
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Rajesh B
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Senthil S
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80983 Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
Patel GC
Investigative Ophthalmology and Visual Science 2019; 60: 1967-1978 (IGR: 20-3)

81221 Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center
Posarelli C
Clinical rheumatology 2019; 38: 2917-2923 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Senthil S
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Wannamaker KW
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80948 MIGS-off-label option for treatment-refractory steroid-induced ocular hypertension
Hohberger B
Ophthalmologe 2020; 117: 62-65 (IGR: 20-3)

80481 The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery
Chan W
American Journal of Ophthalmology 2019; 202: 1-5 (IGR: 20-3)

81454 Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony
Kong X
Ophthalmology. Retina 2019; 3: 993-997 (IGR: 20-3)

80983 Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
Millar JC
Investigative Ophthalmology and Visual Science 2019; 60: 1967-1978 (IGR: 20-3)

80481 The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery
Wiggs JL
American Journal of Ophthalmology 2019; 202: 1-5 (IGR: 20-3)

80948 MIGS-off-label option for treatment-refractory steroid-induced ocular hypertension
Haug M
Ophthalmologe 2020; 117: 62-65 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Thakur M
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81221 Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center
Talarico R
Clinical rheumatology 2019; 38: 2917-2923 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Badakere S
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Zarranz-Ventura J
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

81137 Severe acute ocular hypertension following pulsed methylprednisolone for juvenile idiopathic arthritis
Kelly A
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-3)

81454 Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony
Psaras C
Ophthalmology. Retina 2019; 3: 993-997 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Iezhitsa I
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Kenny S
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Fung AT
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80948 MIGS-off-label option for treatment-refractory steroid-induced ocular hypertension
Bergua A
Ophthalmologe 2020; 117: 62-65 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Rao HL
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

81454 Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony
Stewart JM
Ophthalmology. Retina 2019; 3: 993-997 (IGR: 20-3)

80983 Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
Clark AF
Investigative Ophthalmology and Visual Science 2019; 60: 1967-1978 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Agarwal R
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Ganesh J
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

81221 Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center
Vella G
Clinical rheumatology 2019; 38: 2917-2923 (IGR: 20-3)

80481 The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery
Sobrin L
American Journal of Ophthalmology 2019; 202: 1-5 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Das R
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Mohamed A
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Vassiliev P
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

81221 Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center
Passani A
Clinical rheumatology 2019; 38: 2917-2923 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Mendlovitz A
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80948 MIGS-off-label option for treatment-refractory steroid-induced ocular hypertension
Lämmer R
Ophthalmologe 2020; 117: 62-65 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Busch C
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Krishnamurthy R
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Comstock JM
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Sahoo NK
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Jonnadula GB
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Spasov A
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

81221 Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center
Mosca M
Clinical rheumatology 2019; 38: 2917-2923 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Dikshit S
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Chu ER
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Rodriguez-Valdes PJ
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Choudhari N
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Sangwan V
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Zhukovskaya O
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

81221 Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center
Figus M
Clinical rheumatology 2019; 38: 2917-2923 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Garudadri C
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Anisimova V
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Bahadorani S
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Sarao V
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80991 Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis
Garudadri CS
British Journal of Ophthalmology 2020; 104: 265-269 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Mishra SK
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80449 Intraocular pressure-lowering effects of imidazo1,2-a- and pyrimido1,2-abenzimidazole compounds in rats with dexamethasone-induced ocular hypertension
Ismail NM
European Journal of Pharmacology 2019; 850: 75-87 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Gresores NJ
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80498 Profile of childhood glaucoma at a tertiary center in South India
Mandal AK
Indian Journal of Ophthalmology 2019; 67: 358-365 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Beck KD
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Saatci AO
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Krambeer CJ
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Udaondo Mirete P; Querques G
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Kermany DS; Diaz-Rohena R
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Farah ME; Lanzetta P
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Nolan DP; Sohn JH
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Arevalo JF; Kodjikian L
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

81461 The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
Singer MA
Clinical Ophthalmology 2019; 13: 1079-1086 (IGR: 20-3)

80956 Safety of 6000 intravitreal dexamethasone implants
Chhablani J;
British Journal of Ophthalmology 2020; 104: 39-46 (IGR: 20-3)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Zarranz-Ventura J
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79567 The effect on wound healing of pazopanib and bevacizumab compared with corticosteroid in experimental glaucoma filtration surgery
Kobat SG
International Journal of Ophthalmology 2018; 11: 1909-1915 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Li G
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

79579 The Relationship Between Long-term Use of Intranasal Corticosteroid and Intraocular Pressure
Mohd Zain A
Journal of Glaucoma 2019; 28: 321-324 (IGR: 20-2)

79723 Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome
Bajwa A
International medical case reports journal 2018; 11: 349-358 (IGR: 20-2)

80007 Ocular hypertension secondary to high endogenous steroid load in Cushing's disease
Habib SN
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Sala-Puigdollers A
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

80007 Ocular hypertension secondary to high endogenous steroid load in Cushing's disease
Lin Z
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Lee C
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

79567 The effect on wound healing of pazopanib and bevacizumab compared with corticosteroid in experimental glaucoma filtration surgery
Celiker FU
International Journal of Ophthalmology 2018; 11: 1909-1915 (IGR: 20-2)

79579 The Relationship Between Long-term Use of Intranasal Corticosteroid and Intraocular Pressure
Md Noh UK
Journal of Glaucoma 2019; 28: 321-324 (IGR: 20-2)

79723 Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome
Peck T
International medical case reports journal 2018; 11: 349-358 (IGR: 20-2)

79579 The Relationship Between Long-term Use of Intranasal Corticosteroid and Intraocular Pressure
Hussein S
Journal of Glaucoma 2019; 28: 321-324 (IGR: 20-2)

79723 Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome
Reddy AK
International medical case reports journal 2018; 11: 349-358 (IGR: 20-2)

79567 The effect on wound healing of pazopanib and bevacizumab compared with corticosteroid in experimental glaucoma filtration surgery
Dagli AF
International Journal of Ophthalmology 2018; 11: 1909-1915 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Agrahari V
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Velazquez-Villoria D
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

80007 Ocular hypertension secondary to high endogenous steroid load in Cushing's disease
Puvanachandra N
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-2)

79567 The effect on wound healing of pazopanib and bevacizumab compared with corticosteroid in experimental glaucoma filtration surgery
Kasar K
International Journal of Ophthalmology 2018; 11: 1909-1915 (IGR: 20-2)

79579 The Relationship Between Long-term Use of Intranasal Corticosteroid and Intraocular Pressure
Che Hamzah J
Journal of Glaucoma 2019; 28: 321-324 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Figueras-Roca M
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Wang K
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

79723 Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome
Netland PA
International medical case reports journal 2018; 11: 349-358 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Navarro I
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

79723 Dexamethasone implantation in birdshot chorioretinopathy - long-term outcome
Shildkrot Y
International medical case reports journal 2018; 11: 349-358 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Copete S
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79579 The Relationship Between Long-term Use of Intranasal Corticosteroid and Intraocular Pressure
Mohd Khialdin S; Md Din N
Journal of Glaucoma 2019; 28: 321-324 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Distefano L
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Sherwood JM; Crews K
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
Boixadera A
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Farsiu S
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world
García-Arumi J; Adan A
PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Gonzalez P; Lin CW
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

80064 Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world

PLoS ONE 2019; 14: e0209997 (IGR: 20-2)

79969 In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
Mitra AK; Ethier CR; Stamer WD
Proceedings of the National Academy of Sciences of the United States of America 2019; 116: 1714-1722 (IGR: 20-2)

78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Valenzuela CV
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)

78993 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in Postpenetrating Keratoplasty Steroid-induced Glaucoma: A Case Report
Nazarali S
Journal of Glaucoma 2018; 27: e162-e164 (IGR: 20-1)

78350 Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
Hemarat K
Ophthalmic surgery, lasers & imaging retina 2018; 49: 680-685 (IGR: 20-1)

78837 Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant
Pérez-Sarriegui A
Archivos de la Sociedad Española de Oftalmologia 2018; 93: 580-585 (IGR: 20-1)

78993 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in Postpenetrating Keratoplasty Steroid-induced Glaucoma: A Case Report
Cote SL
Journal of Glaucoma 2018; 27: e162-e164 (IGR: 20-1)

78350 Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
Kemmer JD
Ophthalmic surgery, lasers & imaging retina 2018; 49: 680-685 (IGR: 20-1)

78837 Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant
Casas-Llera P
Archivos de la Sociedad Española de Oftalmologia 2018; 93: 580-585 (IGR: 20-1)

78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Liu JC
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)

78350 Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
Porco TC
Ophthalmic surgery, lasers & imaging retina 2018; 49: 680-685 (IGR: 20-1)

78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Vila PM
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)

78837 Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant
Díez-Álvarez L
Archivos de la Sociedad Española de Oftalmologia 2018; 93: 580-585 (IGR: 20-1)

78993 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in Postpenetrating Keratoplasty Steroid-induced Glaucoma: A Case Report
Gooi P
Journal of Glaucoma 2018; 27: e162-e164 (IGR: 20-1)

78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Simon L
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)

78837 Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant
Contreras I
Archivos de la Sociedad Española de Oftalmologia 2018; 93: 580-585 (IGR: 20-1)

78350 Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
Eaton AM
Ophthalmic surgery, lasers & imaging retina 2018; 49: 680-685 (IGR: 20-1)

78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Doering M
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)

78350 Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
Khurana RN
Ophthalmic surgery, lasers & imaging retina 2018; 49: 680-685 (IGR: 20-1)

78837 Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant
Moreno-López M; Figueroa MS
Archivos de la Sociedad Española de Oftalmologia 2018; 93: 580-585 (IGR: 20-1)

78896 Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis
Lieu JEC
The Laryngoscope 2019; 129: 6-12 (IGR: 20-1)

78350 Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice
Stewart JM
Ophthalmic surgery, lasers & imaging retina 2018; 49: 680-685 (IGR: 20-1)

78837 Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant
González-Martín-Moro J; Muñoz-Negrete FJ; Rebolleda G
Archivos de la Sociedad Española de Oftalmologia 2018; 93: 580-585 (IGR: 20-1)

77519 Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid
Taliaferro K
Clinical orthopaedics and related research 2018; 476: 1420-1425 (IGR: 19-4)

78022 Steroid-induced protracted severe ocular hypertension in a 14-year-old girl
Sousa DC
British Medical Journal (Clinical Research Edition) Case Reports 2018; 2018: (IGR: 19-4)

78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Ganapathy PS
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)

78306 The rescue effect of adalimumab in the treatment of refractory pediatric panuveitis complicated with steroid-induced glaucoma
Ku WN
Taiwan journal of ophthalmology 2018; 8: 164-167 (IGR: 19-4)

78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Lowder CY
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)

78306 The rescue effect of adalimumab in the treatment of refractory pediatric panuveitis complicated with steroid-induced glaucoma
Lin CJ
Taiwan journal of ophthalmology 2018; 8: 164-167 (IGR: 19-4)

77519 Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid
Crawford A
Clinical orthopaedics and related research 2018; 476: 1420-1425 (IGR: 19-4)

78022 Steroid-induced protracted severe ocular hypertension in a 14-year-old girl
Leal I
British Medical Journal (Clinical Research Edition) Case Reports 2018; 2018: (IGR: 19-4)

78306 The rescue effect of adalimumab in the treatment of refractory pediatric panuveitis complicated with steroid-induced glaucoma
Tsai YY
Taiwan journal of ophthalmology 2018; 8: 164-167 (IGR: 19-4)

78022 Steroid-induced protracted severe ocular hypertension in a 14-year-old girl
Abegão Pinto L
British Medical Journal (Clinical Research Edition) Case Reports 2018; 2018: (IGR: 19-4)

78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Arepalli S
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)

77519 Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid
Jabara J
Clinical orthopaedics and related research 2018; 476: 1420-1425 (IGR: 19-4)

78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Baynes K
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)

77519 Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid
Lynch J; Jung E
Clinical orthopaedics and related research 2018; 476: 1420-1425 (IGR: 19-4)

78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Li M
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)

77519 Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid
Zvirbulis R
Clinical orthopaedics and related research 2018; 476: 1420-1425 (IGR: 19-4)

78206 Treatment Duration and Side Effect Profile of Long-Term Use of Intravitreal Preservative-Free Triamcinolone Acetonide in Uveitis
Bena J; Srivastava SK
American Journal of Ophthalmology 2018; 194: 63-71 (IGR: 19-4)

77519 Intraocular Pressure Increases After Intraarticular Knee Injection With Triamcinolone but Not Hyaluronic Acid
Banka T
Clinical orthopaedics and related research 2018; 476: 1420-1425 (IGR: 19-4)

77060 Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension
Kasetti RB
Journal of Biological Chemistry 2018; 293: 9854-9868 (IGR: 19-3)

76485 Canaloplasty in Corticosteroid-Induced Glaucoma. Preliminary Results
Brusini P
Journal of clinical medicine 2018; 7: (IGR: 19-3)

77055 Topical Corticosteroids and Non-steroidal Anti-inflammatory Drugs in the Therapy of Non-infectious Uveitis
Doycheva D
Klinische Monatsblätter für Augenheilkunde 2018; 235: 586-591 (IGR: 19-3)

77316 Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery
Shokoohi-Rad S
Journal of current ophthalmology 2018; 30: 130-135 (IGR: 19-3)

77214 Outcome of Primary Nonpenetrating Deep Sclerectomy in Patients with Steroid-Induced Glaucoma
Elhofi A
Journal of Ophthalmology 2018; 2018: 9215650 (IGR: 19-3)

77055 Topical Corticosteroids and Non-steroidal Anti-inflammatory Drugs in the Therapy of Non-infectious Uveitis
Deuter C
Klinische Monatsblätter für Augenheilkunde 2018; 235: 586-591 (IGR: 19-3)

77316 Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery
Daneshvar R
Journal of current ophthalmology 2018; 30: 130-135 (IGR: 19-3)

77214 Outcome of Primary Nonpenetrating Deep Sclerectomy in Patients with Steroid-Induced Glaucoma
Helaly HA
Journal of Ophthalmology 2018; 2018: 9215650 (IGR: 19-3)

76485 Canaloplasty in Corticosteroid-Induced Glaucoma. Preliminary Results
Tosoni C
Journal of clinical medicine 2018; 7: (IGR: 19-3)

77060 Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension
Maddineni P
Journal of Biological Chemistry 2018; 293: 9854-9868 (IGR: 19-3)

77316 Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery
Jafarian-Shahri M
Journal of current ophthalmology 2018; 30: 130-135 (IGR: 19-3)

77060 Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension
Patel PD
Journal of Biological Chemistry 2018; 293: 9854-9868 (IGR: 19-3)

77055 Topical Corticosteroids and Non-steroidal Anti-inflammatory Drugs in the Therapy of Non-infectious Uveitis
Grajewski R
Klinische Monatsblätter für Augenheilkunde 2018; 235: 586-591 (IGR: 19-3)

76485 Canaloplasty in Corticosteroid-Induced Glaucoma. Preliminary Results
Zeppieri M
Journal of clinical medicine 2018; 7: (IGR: 19-3)

77060 Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension
Searby C
Journal of Biological Chemistry 2018; 293: 9854-9868 (IGR: 19-3)

77316 Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery
Rajaee P
Journal of current ophthalmology 2018; 30: 130-135 (IGR: 19-3)

77060 Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension
Sheffield VC; Zode GS
Journal of Biological Chemistry 2018; 293: 9854-9868 (IGR: 19-3)

75528 Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series
Winterhalter S; Behrens UD; Salchow D; Joussen AM; Pleyer U
BMC Ophthalmology 2017; 17: 252 (IGR: 19-2)

74726 INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS
Srinivasan R
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Chang LS
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Zhao Y
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Shan SW
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74443 Steroid-Induced Glaucoma as a Complication of Atopic Eczema Local Treatment
Řeháková T
?eska a Slovenska Oftalmologie 2017; 73: 64-68 (IGR: 19-1)

74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Yasuda M
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)

74754 YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells
Peng J
International Journal of Molecular Medicine 2018; 41: 164-172 (IGR: 19-1)

74418 Steroid-induced Glaucoma: An Avoidable Irreversible Blindness
Phulke S
Journal of Current Glaucoma Practice 2017; 11: 67-72 (IGR: 19-1)

74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Sudhalkar A
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74765 Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture
Shields CL
Indian Journal of Ophthalmology 2017; 65: 1093-1104 (IGR: 19-1)

74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Takayama K
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)

74754 YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells
Wang H
International Journal of Molecular Medicine 2018; 41: 164-172 (IGR: 19-1)

74765 Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture
Roelofs K
Indian Journal of Ophthalmology 2017; 65: 1093-1104 (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Su BG
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74726 INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS
Sharma U
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74418 Steroid-induced Glaucoma: An Avoidable Irreversible Blindness
Kaushik S
Journal of Current Glaucoma Practice 2017; 11: 67-72 (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Lee HC
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Kodjikian L
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74443 Steroid-Induced Glaucoma as a Complication of Atopic Eczema Local Treatment
Stepanov A
?eska a Slovenska Oftalmologie 2017; 73: 64-68 (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Do CW
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74765 Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture
Di Nicola M
Indian Journal of Ophthalmology 2017; 65: 1093-1104 (IGR: 19-1)

74443 Steroid-Induced Glaucoma as a Complication of Atopic Eczema Local Treatment
Jirásková N
?eska a Slovenska Oftalmologie 2017; 73: 64-68 (IGR: 19-1)

74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Chhablani J
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Xiao HJ
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74726 INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS
George R
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Lam TC
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Kanda T
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Tsai YC
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74754 YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells
Wang X
International Journal of Molecular Medicine 2018; 41: 164-172 (IGR: 19-1)

74418 Steroid-induced Glaucoma: An Avoidable Irreversible Blindness
Kaur S
Journal of Current Glaucoma Practice 2017; 11: 67-72 (IGR: 19-1)

74726 INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS
Raman R
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Shen LS
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74418 Steroid-induced Glaucoma: An Avoidable Irreversible Blindness
Pandav SS
Journal of Current Glaucoma Practice 2017; 11: 67-72 (IGR: 19-1)

74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Bhojwani D
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Taguchi M
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)

74754 YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells
Sun M
International Journal of Molecular Medicine 2018; 41: 164-172 (IGR: 19-1)

74765 Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture
Sioufi K
Indian Journal of Ophthalmology 2017; 65: 1093-1104 (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Kong RPW
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Zhang HW
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Someya H
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)

74726 INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS
Sharma T
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74754 YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells
Deng S
International Journal of Molecular Medicine 2018; 41: 164-172 (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Li CL
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74765 Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture
Mashayekhi A
Indian Journal of Ophthalmology 2017; 65: 1093-1104 (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Liu XY
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Li KK
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74568 INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Vasavada A
Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Chun KM
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74765 Uveal effusion syndrome in 104 eyes: Response to corticosteroids - The 2017 Axel C. Hansen lecture
Shields JA
Indian Journal of Ophthalmology 2017; 65: 1093-1104 (IGR: 19-1)

74495 Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
Takeuchi M
PLoS ONE 2017; 12: e0185305 (IGR: 19-1)

74754 YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells
Wang Y
International Journal of Molecular Medicine 2018; 41: 164-172 (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Liu SF
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Wang F
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74726 INTRAOCULAR PRESSURE CHANGES AFTER DEXAMETHASONE IMPLANT IN PATIENTS WITH GLAUCOMA AND STEROID RESPONDERS

Retina (Philadelphia, Pa.) 2017; 0: (IGR: 19-1)

74618 Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome
Ding J
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2017; 49: 794-797 (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
Stamer WD
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

74835 Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study
Kuo HC
Oncotarget 2017; 8: 105463-105471 (IGR: 19-1)

74400 New Insight of Common Regulatory Pathways in Human Trabecular Meshwork Cells in Response to Dexamethasone and Prednisolone Using an Integrated Quantitative Proteomics: SWATH and MRM-HR Mass Spectrometry
To CH
Journal of Proteome Research 2017; 16: 3753-3765 (IGR: 19-1)

73048 Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells
Liu Q
Current Eye Research 2017; 0: 1-6 (IGR: 18-4)

73078 Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome
Agrawal V
Journal of clinical and diagnostic research : JCDR 2017; 11: SC05-SC06 (IGR: 18-4)

72955 Cytomegalovirus Anterior Uveitis Following Topical Cyclosporine A
Siak J; Chee SP
Ocular Immunology and Inflammation 2017; 0: 1-4 (IGR: 18-4)

73048 Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells
Ye Y
Current Eye Research 2017; 0: 1-6 (IGR: 18-4)

73078 Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome
Devpura K; Mishra L
Journal of clinical and diagnostic research : JCDR 2017; 11: SC05-SC06 (IGR: 18-4)

73048 Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells
Lin X; Yang Y
Current Eye Research 2017; 0: 1-6 (IGR: 18-4)

73078 Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome
Agarwal S
Journal of clinical and diagnostic research : JCDR 2017; 11: SC05-SC06 (IGR: 18-4)

73048 Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells
Wu K; Yu M
Current Eye Research 2017; 0: 1-6 (IGR: 18-4)

71286 Steroid-induced glaucoma in the pediatric population
Nuyen B
Journal of AAPOS 2017; 21: 1-6 (IGR: 18-3)

71441 Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration
Patel GC
American Journal of Pathology 2017; 187: 713-723 (IGR: 18-3)

71576 Cross-linked actin networks (CLANs) in glaucoma
Bermudez JY
Experimental Eye Research 2017; 159: 16-22 (IGR: 18-3)

71334 Impact of Drugs on Glaucoma and Intraocular Pressure
Schlote T
Klinische Monatsblätter für Augenheilkunde 2017; 234: 179-184 (IGR: 18-3)

71193 Trabecular Micro-Bypass Stent Use in Necrotizing Scleritis
Sandhu S
Journal of Glaucoma 2017; 26: e96-e98 (IGR: 18-3)

71293 Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients
Caplan A
Journal of the American Academy of Dermatology 2017; 76: 201-207 (IGR: 18-3)

71576 Cross-linked actin networks (CLANs) in glaucoma
Montecchi-Palmer M
Experimental Eye Research 2017; 159: 16-22 (IGR: 18-3)

71193 Trabecular Micro-Bypass Stent Use in Necrotizing Scleritis
Heckler L
Journal of Glaucoma 2017; 26: e96-e98 (IGR: 18-3)

71293 Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients
Fett N
Journal of the American Academy of Dermatology 2017; 76: 201-207 (IGR: 18-3)

71286 Steroid-induced glaucoma in the pediatric population
Weinreb RN
Journal of AAPOS 2017; 21: 1-6 (IGR: 18-3)

71441 Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration
Phan TN
American Journal of Pathology 2017; 187: 713-723 (IGR: 18-3)

71293 Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients
Rosenbach M
Journal of the American Academy of Dermatology 2017; 76: 201-207 (IGR: 18-3)

71286 Steroid-induced glaucoma in the pediatric population
Robbins SL
Journal of AAPOS 2017; 21: 1-6 (IGR: 18-3)

71441 Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration
Maddineni P
American Journal of Pathology 2017; 187: 713-723 (IGR: 18-3)

71576 Cross-linked actin networks (CLANs) in glaucoma
Mao W
Experimental Eye Research 2017; 159: 16-22 (IGR: 18-3)

71193 Trabecular Micro-Bypass Stent Use in Necrotizing Scleritis
Mah D
Journal of Glaucoma 2017; 26: e96-e98 (IGR: 18-3)

71293 Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients
Werth VP
Journal of the American Academy of Dermatology 2017; 76: 201-207 (IGR: 18-3)

71441 Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration
Kasetti RB
American Journal of Pathology 2017; 187: 713-723 (IGR: 18-3)

71193 Trabecular Micro-Bypass Stent Use in Necrotizing Scleritis
Dorey MW
Journal of Glaucoma 2017; 26: e96-e98 (IGR: 18-3)

71576 Cross-linked actin networks (CLANs) in glaucoma
Clark AF
Experimental Eye Research 2017; 159: 16-22 (IGR: 18-3)

71293 Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients
Micheletti RG
Journal of the American Academy of Dermatology 2017; 76: 201-207 (IGR: 18-3)

71441 Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration
Millar JC; Clark AF; Zode GS
American Journal of Pathology 2017; 187: 713-723 (IGR: 18-3)

70549 The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Black RJ
PLoS ONE 2016; 11: e0166468 (IGR: 18-2)

70710 Intraocular Pressure after Intravitreal Triesence Injection
Atchison EA
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Malclès A
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Hennein L
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70434 Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone
Dismuke WM
PLoS ONE 2016; 11: e0165326 (IGR: 18-2)

70765 Inhaled corticosteroids: Ocular safety and the hypothalamic-pituitary-adrenal axis
Carr WW
Annals of Allergy Asthma and Immunology 2016; 117: 589-594 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Wilson JC
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70929 Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
Nath T
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017; 6: 28-32 (IGR: 18-2)

70874 A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing
Bermudez JY
PLoS ONE 2017; 12: e0169671 (IGR: 18-2)

70604 Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension
Theodoropoulou S
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 725-732 (IGR: 18-2)

70763 Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma
Ngai P
Medicine 2016; 95: e5383 (IGR: 18-2)

70683 A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
Kusne Y
Clinical Ophthalmology 2016; 10: 2329-2336 (IGR: 18-2)

70766 Safety of intranasal corticosteroids
Bensch GW
Annals of Allergy Asthma and Immunology 2016; 117: 601-605 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Chin EK
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Fini ME
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70891 ExPRESS Mini-Shunt as a Treatment Alternative for Medically Uncontrolled Steroid-Induced Glaucoma in a Pediatric Patient
Choy BN
Case Reports in Ophthalmology 2016; 7: 270-276 (IGR: 18-2)

70723 Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
Li G
Experimental Eye Research 2016; 155: 38-46 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Wilson JC
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Sarsour K
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Almeida DR
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70891 ExPRESS Mini-Shunt as a Treatment Alternative for Medically Uncontrolled Steroid-Induced Glaucoma in a Pediatric Patient
Wong MO
Case Reports in Ophthalmology 2016; 7: 270-276 (IGR: 18-2)

70604 Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension
Ellabban AA
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 725-732 (IGR: 18-2)

70929 Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
Roy SS
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017; 6: 28-32 (IGR: 18-2)

70874 A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing
Webber HC
PLoS ONE 2017; 12: e0169671 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Dot C
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70710 Intraocular Pressure after Intravitreal Triesence Injection
Bakri SJ
Seminars in Ophthalmology 2016; 0: 1-5 (IGR: 18-2)

70723 Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
Cui G
Experimental Eye Research 2016; 155: 38-46 (IGR: 18-2)

70549 The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Hill CL
PLoS ONE 2016; 11: e0166468 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Sarsour K
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Schwartz SG
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Hou J
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70763 Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma
Kim G
Medicine 2016; 95: e5383 (IGR: 18-2)

70683 A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
Kang P
Clinical Ophthalmology 2016; 10: 2329-2336 (IGR: 18-2)

70434 Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone
Klingeborn M
PLoS ONE 2016; 11: e0165326 (IGR: 18-2)

70765 Inhaled corticosteroids: Ocular safety and the hypothalamic-pituitary-adrenal axis
Szefler SJ
Annals of Allergy Asthma and Immunology 2016; 117: 589-594 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Stewart JM
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70763 Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma
Chak G
Medicine 2016; 95: e5383 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Velez G
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70549 The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Lester S
PLoS ONE 2016; 11: e0166468 (IGR: 18-2)

70929 Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
Kumar H
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017; 6: 28-32 (IGR: 18-2)

70683 A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
Fintelmann RE
Clinical Ophthalmology 2016; 10: 2329-2336 (IGR: 18-2)

70874 A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing
Brown B
PLoS ONE 2017; 12: e0169671 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Collinson N
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70434 Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone
Stamer WD
PLoS ONE 2016; 11: e0165326 (IGR: 18-2)

70891 ExPRESS Mini-Shunt as a Treatment Alternative for Medically Uncontrolled Steroid-Induced Glaucoma in a Pediatric Patient
Chan JC
Case Reports in Ophthalmology 2016; 7: 270-276 (IGR: 18-2)

70604 Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension
Johnston RL
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 725-732 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Gao X
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Voirin N
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70723 Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
Dismuke WM
Experimental Eye Research 2016; 155: 38-46 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Collinson N
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70874 A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing
Braun TA
PLoS ONE 2017; 12: e0169671 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Jeong S
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Tuckwell K
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70891 ExPRESS Mini-Shunt as a Treatment Alternative for Medically Uncontrolled Steroid-Induced Glaucoma in a Pediatric Patient
Lai CH
Case Reports in Ophthalmology 2016; 7: 270-276 (IGR: 18-2)

70604 Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension
Cilliers H
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 725-732 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Xu K
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Lowry EA
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70763 Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma
Lin K
Medicine 2016; 95: e5383 (IGR: 18-2)

70929 Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
Agrawal R
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017; 6: 28-32 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Tuckwell K
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70549 The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Dixon WG
PLoS ONE 2016; 11: e0166468 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Vié AL
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70723 Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
Navarro I; Perkumas K
Experimental Eye Research 2016; 155: 38-46 (IGR: 18-2)

70763 Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma
Maeda M
Medicine 2016; 95: e5383 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Agard É
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Musselman D
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Patel N
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70929 Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
Kumar S
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017; 6: 28-32 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Jiang Z
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70874 A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing
Clark AF
PLoS ONE 2017; 12: e0169671 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Peraire M
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Musselman D
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70891 ExPRESS Mini-Shunt as a Treatment Alternative for Medically Uncontrolled Steroid-Induced Glaucoma in a Pediatric Patient
Lai JS
Case Reports in Ophthalmology 2016; 7: 270-276 (IGR: 18-2)

70604 Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension
Mohamed Q
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 725-732 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Klearman M
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70723 Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
Woodward DF
Experimental Eye Research 2016; 155: 38-46 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Corbella M
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Itakura T
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Klearman M
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70874 A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing
Mao W
PLoS ONE 2017; 12: e0169671 (IGR: 18-2)

70604 Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension
Sallam AB
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 725-732 (IGR: 18-2)

70763 Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma
Mosaed S
Medicine 2016; 95: e5383 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Enanoria WT
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Bellocq D
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70929 Prevalence of Steroid-Induced Cataract and Glaucoma in Chronic Obstructive Pulmonary Disease Patients Attending a Tertiary Care Center in India
Satsangi SK
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2017; 6: 28-32 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Napalkov P
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70054 Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert)
Han Y
Journal of Glaucoma 2016; 25: e772-e776 (IGR: 18-2)

70723 Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells
Stamer WD
Experimental Eye Research 2016; 155: 38-46 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Denis P
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Napalkov P
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Price MO
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Elshatory YM
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Jick SS
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Price FW
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Jick SS
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Kodjikian L
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Kwon YH
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Stone JH
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Varma R
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Stone JH
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Gehrs KM
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Stamer WD
Progress in Retinal and Eye Research 2017; 56: 58-83 (IGR: 18-2)

70534 Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis
Meier CR
Seminars in Arthritis & Rheumatism 2017; 46: 650-656 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Boldt HC
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

70859 Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis
Meier CR
Seminars in Arthritis & Rheumatism 2017; 46: 819-827 (IGR: 18-2)

70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Sohn EH; Russell SR; Folk JC; Mahajan VB
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351 (IGR: 18-2)

69380 Model systems for the study of steroid-induced IOP elevation
Rybkin I
Experimental Eye Research 2017; 158: 51-58 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Vié AL
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Cham A
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Dang Y
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Goñi FJ
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Broder MS
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

68870 Delivery of steroids into the eye for the treatment of macular edema
Hadayer A
Expert Opinion on Drug Delivery 2016; 13: 1083-1091 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Bansal M
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Stalmans I
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Kodjikian L
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Kaplowitz K
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

68870 Delivery of steroids into the eye for the treatment of macular edema
Schaal S
Expert Opinion on Drug Delivery 2016; 13: 1083-1091 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Sarsour K
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

69380 Model systems for the study of steroid-induced IOP elevation
Gerometta R
Experimental Eye Research 2017; 158: 51-58 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Chang E
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

69380 Model systems for the study of steroid-induced IOP elevation
Fridman G
Experimental Eye Research 2017; 158: 51-58 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Malclès A
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Banda HK
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Denis P
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Parikh HA
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Nordmann JP
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Roy P
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

69380 Model systems for the study of steroid-induced IOP elevation
Candia O
Experimental Eye Research 2017; 158: 51-58 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Collinson N
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Agard E
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Kwon Y
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Taylor S
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Loewen RT
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

69380 Model systems for the study of steroid-induced IOP elevation
Danias J
Experimental Eye Research 2017; 158: 51-58 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Tuckwell K
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Tlucek PS
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Voirin N
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Napalkov P
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Francis BA
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Bassuk AG
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Diestelhorst M
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
El Chehab H
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69279 Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis
Klearman M
Seminars in Arthritis & Rheumatism 2016; 46: 246-252 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Tsang SH
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Figueiredo AR
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Nguyen AM
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

69214 Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma
Loewen NA
Clinical and Experimental Ophthalmology 2016; 44: 783-788 (IGR: 18-1)

69410 TOLERANCE OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA
Dot C
Retina (Philadelphia, Pa.) 2017; 37: 173-178 (IGR: 18-1)

68936 Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
Garway-Heath DF
Ophthalmology and therapy 2016; 5: 47-61 (IGR: 18-1)

69292 Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
Sobol WM; Folk JC; Yeh S; Mahajan VB
Clinical Ophthalmology 2016; 10: 1187-1197 (IGR: 18-1)

66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Borrás T
Gene Therapy 2016; 23: 438-449 (IGR: 17-4)

67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Gregory AC
Seminars in Ophthalmology 2016; 0: 0 (IGR: 17-4)

66704 Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
Chan LW
Journal of Glaucoma 2016; 25: e268-e272 (IGR: 17-4)

67253 Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Sheppard JD
Advances in Therapy 2016; 33: 532-552 (IGR: 17-4)

67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Golakiya HN
Current drug safety 2016; 0: (IGR: 17-4)

66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Gosling AA
Veterinary Ophthalmology 2016; 19: 69-76 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Sato K
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Wise J
Retinal cases & brief reports 2017; 11: 79-82 (IGR: 17-4)

66753 Ocular changes induced by drugs commonly used in dermatology
Turno-Kręcicka A
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Moss EB
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

67280 Vernal Keratoconjunctivitis in Kashmir: A temperate zone
Sofi RA
International Ophthalmology 2016; 36: 875-879 (IGR: 17-4)

67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Hirapara HN
Current drug safety 2016; 0: (IGR: 17-4)

67280 Vernal Keratoconjunctivitis in Kashmir: A temperate zone
Mufti A
International Ophthalmology 2016; 36: 875-879 (IGR: 17-4)

66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Kiland JA
Veterinary Ophthalmology 2016; 19: 69-76 (IGR: 17-4)

67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Zhang MM
Seminars in Ophthalmology 2016; 0: 0 (IGR: 17-4)

66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Buie LK
Gene Therapy 2016; 23: 438-449 (IGR: 17-4)

66704 Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
Hsu WC
Journal of Glaucoma 2016; 25: e268-e272 (IGR: 17-4)

67253 Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Comstock TL
Advances in Therapy 2016; 33: 532-552 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Nishiguchi KM
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Toygar O
Retinal cases & brief reports 2017; 11: 79-82 (IGR: 17-4)

66753 Ocular changes induced by drugs commonly used in dermatology
Grzybowski A
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Buys YM
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Corrêa ZM
Retinal cases & brief reports 2017; 11: 79-82 (IGR: 17-4)

66828 Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
Spiga MG
Gene Therapy 2016; 23: 438-449 (IGR: 17-4)

67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Rapoport Y
Seminars in Ophthalmology 2016; 0: 0 (IGR: 17-4)

66704 Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
Hsieh YT
Journal of Glaucoma 2016; 25: e268-e272 (IGR: 17-4)

67253 Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Cavet ME
Advances in Therapy 2016; 33: 532-552 (IGR: 17-4)

67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Parmar SJ
Current drug safety 2016; 0: (IGR: 17-4)

66753 Ocular changes induced by drugs commonly used in dermatology
Misiuk-Hojło M
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)

66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Rutkowski LE
Veterinary Ophthalmology 2016; 19: 69-76 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Low SA
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Maruyama K
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Hoefs A
Veterinary Ophthalmology 2016; 19: 69-76 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Yuen D
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Miller DM
Retinal cases & brief reports 2017; 11: 79-82 (IGR: 17-4)

67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Naik VN
Current drug safety 2016; 0: (IGR: 17-4)

66753 Ocular changes induced by drugs commonly used in dermatology
Patryn E
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)

67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Ling JD
Seminars in Ophthalmology 2016; 0: 0 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Moritoh S
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

66753 Ocular changes induced by drugs commonly used in dermatology
Czajor K
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)

67597 Triamcinolone Acetonide and Bevacizumab Induced Raised Intraocular Pressure in An Elderly Male Diabetic Patient - A Case Report
Tripathi CB
Current drug safety 2016; 0: (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Fujita K
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

67271 SUBRETINAL CANNULATION AS A COMPLICATION OF SUTURE TRABECULOTOMY SURGERY IN A PEDIATRIC PATIENT
Sisk RA
Retinal cases & brief reports 2017; 11: 79-82 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Jin YP
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

67523 Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment
Kuchtey RW
Seminars in Ophthalmology 2016; 0: 0 (IGR: 17-4)

66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
Ellinwood NM
Veterinary Ophthalmology 2016; 19: 69-76 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Ikuta Y
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

66753 Ocular changes induced by drugs commonly used in dermatology
Nita M
Clinics in Dermatology 2016; 34: 129-137 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Chapman KR
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

66790 Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats
McLellan GJ
Veterinary Ophthalmology 2016; 19: 69-76 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Kasai H
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

67529 A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study
Trope GE
Journal of Glaucoma 2017; 26: 182-186 (IGR: 17-4)

67264 Topical ocular dexamethasone decreases intraocular pressure and body weight in rats
Nakazawa T
Journal of negative results in biomedicine 2016; 15: 5 (IGR: 17-4)

65976 Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study
Moore DB
Ophthalmology and therapy 2015; 4: 103-113 (IGR: 17-3)

65897 Complications of Descemet's membrane endothelial keratoplasty
Spaniol K
Ophthalmologe 2015; 112: 974-981 (IGR: 17-3)

65919 Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly
Battaglia S
Drugs and Aging 2015; 32: 1067-1076 (IGR: 17-3)

66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Ozkaya A
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)

65976 Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study
Stinnett S
Ophthalmology and therapy 2015; 4: 103-113 (IGR: 17-3)

65919 Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly
Cardillo I
Drugs and Aging 2015; 32: 1067-1076 (IGR: 17-3)

65897 Complications of Descemet's membrane endothelial keratoplasty
Borrelli M
Ophthalmologe 2015; 112: 974-981 (IGR: 17-3)

66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Alagoz C
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)

65897 Complications of Descemet's membrane endothelial keratoplasty
Holtmann C
Ophthalmologe 2015; 112: 974-981 (IGR: 17-3)

66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Alagoz N
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)

65976 Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study
Jaffe GJ
Ophthalmology and therapy 2015; 4: 103-113 (IGR: 17-3)

65919 Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly
Lavorini F
Drugs and Aging 2015; 32: 1067-1076 (IGR: 17-3)

66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Gunes H
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)

65919 Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly
Spatafora M
Drugs and Aging 2015; 32: 1067-1076 (IGR: 17-3)

65897 Complications of Descemet's membrane endothelial keratoplasty
Schrader S
Ophthalmologe 2015; 112: 974-981 (IGR: 17-3)

65976 Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study
Asrani S
Ophthalmology and therapy 2015; 4: 103-113 (IGR: 17-3)

65919 Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly
Scichilone N
Drugs and Aging 2015; 32: 1067-1076 (IGR: 17-3)

65897 Complications of Descemet's membrane endothelial keratoplasty
Geerling G
Ophthalmologe 2015; 112: 974-981 (IGR: 17-3)

66317 Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience
Yilmaz I; Perente I; Yazici AT; Taskapili M
European Journal of Ophthalmology 2015; 0: 0 (IGR: 17-3)

61678 Incidence of endogenous intraocular inflammation patients who visited Nippon Medical School Hospital during the 8 years from 2004 to 2012
Serizawa M
Nippon Ganka Gakkai Zasshi 2015; 119: 347-353 (IGR: 17-1)

61766 SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Dedania VS
Retina (Philadelphia, Pa.) 2015; 35: 841-858 (IGR: 17-1)

61679 Goniotomy for Steroid-Induced Glaucoma: Clinical and Tonographic Evidence to Support Therapeutic Goniotomy
Choi EY
Journal of Pediatric Ophthalmology & Strabismus 2015; 52: 183-188 (IGR: 17-1)

61418 Animal models of glucocorticoid-induced glaucoma
Overby DR
Experimental Eye Research 2015; 141: 15-22 (IGR: 17-1)

61091 Steroid-induced glaucoma and childhood blindness
Gupta S
British Journal of Ophthalmology 2015; 99: 1454-1456 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Lam WC
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Guigou S
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61627 OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
Reid GA
Retina (Philadelphia, Pa.) 2015; 35: 1647-1655 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Raghunathan VK
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Nas K
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Ozkurt YB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Morgan JT
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61678 Incidence of endogenous intraocular inflammation patients who visited Nippon Medical School Hospital during the 8 years from 2004 to 2012
Kunishige T
Nippon Ganka Gakkai Zasshi 2015; 119: 347-353 (IGR: 17-1)

61627 OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
Sahota DS
Retina (Philadelphia, Pa.) 2015; 35: 1647-1655 (IGR: 17-1)

61766 SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Bakri SJ
Retina (Philadelphia, Pa.) 2015; 35: 841-858 (IGR: 17-1)

61679 Goniotomy for Steroid-Induced Glaucoma: Clinical and Tonographic Evidence to Support Therapeutic Goniotomy
Walton DS
Journal of Pediatric Ophthalmology & Strabismus 2015; 52: 183-188 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Albiani DA
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61418 Animal models of glucocorticoid-induced glaucoma
Clark AF
Experimental Eye Research 2015; 141: 15-22 (IGR: 17-1)

61091 Steroid-induced glaucoma and childhood blindness
Shah P
British Journal of Ophthalmology 2015; 99: 1454-1456 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Karkucak M
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Akkaya S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Pommier S
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61627 OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS
Sarhan M
Retina (Philadelphia, Pa.) 2015; 35: 1647-1655 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Meyer F
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Durmus B
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Aksoy S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Park SA
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Yoganathan P
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61678 Incidence of endogenous intraocular inflammation patients who visited Nippon Medical School Hospital during the 8 years from 2004 to 2012
Ito Y
Nippon Ganka Gakkai Zasshi 2015; 119: 347-353 (IGR: 17-1)

61091 Steroid-induced glaucoma and childhood blindness
Grewal S
British Journal of Ophthalmology 2015; 99: 1454-1456 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Karatay S
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Evciman T
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Chen JC
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61091 Steroid-induced glaucoma and childhood blindness
Chaurasia AK
British Journal of Ophthalmology 2015; 99: 1454-1456 (IGR: 17-1)

61678 Incidence of endogenous intraocular inflammation patients who visited Nippon Medical School Hospital during the 8 years from 2004 to 2012
Tsukada R
Nippon Ganka Gakkai Zasshi 2015; 119: 347-353 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Hajjar C
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Weber D
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Kherani A
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Haboğlu M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Phinney BS
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Merite PY
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61678 Incidence of endogenous intraocular inflammation patients who visited Nippon Medical School Hospital during the 8 years from 2004 to 2012
Hori J
Nippon Ganka Gakkai Zasshi 2015; 119: 347-353 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Capkın E
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61091 Steroid-induced glaucoma and childhood blindness
Gupta V
British Journal of Ophthalmology 2015; 99: 1454-1456 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Parrat E
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Maberley DA
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Murphy CJ
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Kaya A; Ucmak D
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61276 Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix
Russell P
Investigative Ophthalmology and Visual Science 2015; 56: 4447-4459 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Rouhette H
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Oliver A
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Rebollo O
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Akar ZA
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Rabinovitch T
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Matonti F
Ophthalmologica 2015; 233: 169-175 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Cevik R
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Sheidow TG; Tourville E
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Kilic E
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Wittenberg LA
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Kilic G
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Sigouin C
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

61576 Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis
Ozgocmen S
International journal of rheumatic diseases 2015; 18: 873-879 (IGR: 17-1)

61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Baptiste DC
Clinical Ophthalmology 2015; 9: 1255-1268 (IGR: 17-1)

60418 Outcome of Ocular Steroid Hypertensive Response in Children
Kaur S
Journal of Glaucoma 2016; 25: 343-347 (IGR: 16-4)

60521 Clinical relevance of the glucocorticoid receptor gene polymorphisms in glucocorticoid-induced ocular hypertension and primary open angle glaucoma
Wang XQ
International Journal of Ophthalmology 2015; 8: 169-173 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Augustin AJ
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60580 Corneal biomechanics in steroid induced ocular hypertension
Yülek F
Contact Lens and Anterior Eye 2015; 38: 181-184 (IGR: 16-4)

60423 Topical difluprednate for the treatment of Harada's disease
Onishi SM
Clinical Ophthalmology 2015; 9: 157-167 (IGR: 16-4)

60745 Transient glaucoma after an epidural steroid injection: a case report
Manjiani D
Ochsner Journal 2015; 15: 79-82 (IGR: 16-4)

60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Caillaux V
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Jeong S
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Jiménez-Gómez B
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)

60562 Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant
Parekh A
JAMA ophthalmology 2015; 133: 568-573 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Freitas-Neto CA
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Valtot F
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Patel N
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60745 Transient glaucoma after an epidural steroid injection: a case report
Said S
Ochsner Journal 2015; 15: 79-82 (IGR: 16-4)

60521 Clinical relevance of the glucocorticoid receptor gene polymorphisms in glucocorticoid-induced ocular hypertension and primary open angle glaucoma
Duan ZX
International Journal of Ophthalmology 2015; 8: 169-173 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Holz FG
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Maghsoudlou A
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60423 Topical difluprednate for the treatment of Harada's disease
Asahi MG
Clinical Ophthalmology 2015; 9: 157-167 (IGR: 16-4)

60562 Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant
Srivastava S
JAMA ophthalmology 2015; 133: 568-573 (IGR: 16-4)

60580 Corneal biomechanics in steroid induced ocular hypertension
Gerçeker S
Contact Lens and Anterior Eye 2015; 38: 181-184 (IGR: 16-4)

60418 Outcome of Ocular Steroid Hypertensive Response in Children
Dhiman I
Journal of Glaucoma 2016; 25: 343-347 (IGR: 16-4)

60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
González-Montpetit M
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Haritoglou C
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60580 Corneal biomechanics in steroid induced ocular hypertension
Akçay E
Contact Lens and Anterior Eye 2015; 38: 181-184 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Dhanireddy S
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Fonollosa Calduch A
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Edlund CC
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60423 Topical difluprednate for the treatment of Harada's disease
Chou C
Clinical Ophthalmology 2015; 9: 157-167 (IGR: 16-4)

60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Souied EH
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60418 Outcome of Ocular Steroid Hypertensive Response in Children
Kaushik S
Journal of Glaucoma 2016; 25: 343-347 (IGR: 16-4)

60745 Transient glaucoma after an epidural steroid injection: a case report
Kaye AD
Ochsner Journal 2015; 15: 79-82 (IGR: 16-4)

60521 Clinical relevance of the glucocorticoid receptor gene polymorphisms in glucocorticoid-induced ocular hypertension and primary open angle glaucoma
He XG
International Journal of Ophthalmology 2015; 8: 169-173 (IGR: 16-4)

60562 Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant
Bena J
JAMA ophthalmology 2015; 133: 568-573 (IGR: 16-4)

60423 Topical difluprednate for the treatment of Harada's disease
Gallemore RP
Clinical Ophthalmology 2015; 9: 157-167 (IGR: 16-4)

60562 Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant
Albini T
JAMA ophthalmology 2015; 133: 568-573 (IGR: 16-4)

60598 Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion
Mimoun G
European Journal of Ophthalmology 2015; 0: 0 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Payal A
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Orive Bañuelos A
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Mayer WJ
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60580 Corneal biomechanics in steroid induced ocular hypertension
Saraç Ö
Contact Lens and Anterior Eye 2015; 38: 181-184 (IGR: 16-4)

60418 Outcome of Ocular Steroid Hypertensive Response in Children
Raj S
Journal of Glaucoma 2016; 25: 343-347 (IGR: 16-4)

60521 Clinical relevance of the glucocorticoid receptor gene polymorphisms in glucocorticoid-induced ocular hypertension and primary open angle glaucoma
Zhou XY
International Journal of Ophthalmology 2015; 8: 169-173 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Hartiala J
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60708 Effects of ozurdex on intraocular pressure. A real life clinical practice study
Valsero Franco S
Archivos de la Sociedad Española de Oftalmologia 2015; 90: 421-425 (IGR: 16-4)

60580 Corneal biomechanics in steroid induced ocular hypertension
Çağıl N
Contact Lens and Anterior Eye 2015; 38: 181-184 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Boonsopon S
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Hazelett D
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60418 Outcome of Ocular Steroid Hypertensive Response in Children
Pandav SS
Journal of Glaucoma 2016; 25: 343-347 (IGR: 16-4)

60562 Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant
Nguyen QD
JAMA ophthalmology 2015; 133: 568-573 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Bopp S
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Ratwatte MD
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60562 Risk Factors Associated With Intraocular Pressure Increase in Patients With Uveitis Treated With the Fluocinolone Acetonide Implant
Goldstein DA
JAMA ophthalmology 2015; 133: 568-573 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Scheuerle AF
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Itakura T; Wu PC
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Maier M
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60180 Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants
Foster CS
Ocular Immunology and Inflammation 2014; 0: 1-5 (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Sekundo W
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Avery RL
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Sandner D
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Davis J
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Shirlaw A
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Flynn HW; Lalwani G
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Hattenbach LO
Ophthalmologica 2015; 233: 18-26 (IGR: 16-4)

60703 Identification of a Novel Mucin Gene HCG22 Associated with Steroid-Induced Ocular Hypertension
Puliafito CA; Wafapoor H; Hijikata M; Keicho N; Gao XA; Argueso P; Allayee H; Coetzee GA; Pletcher MT; Conti DV; Schwartz SG; Eaton AM; Fini ME
Investigative Ophthalmology and Visual Science 2015; 0: (IGR: 16-4)

58768 Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Investigative Ophthalmology and Visual Science 2014; 55: 4922-4933 (IGR: 16-3)

58735 Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension
Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
Clinical and Experimental Ophthalmology 2015; 43: 54-66 (IGR: 16-3)

59115 Safety considerations of inhaled corticosteroids in the elderly
Battaglia S; Cardillo I; Lavorini F; Spatafora M; Scichilone N
Drugs and Aging 2014; 31: 787-796 (IGR: 16-3)

59619 NFATc1 activity regulates the expression of myocilin induced by dexamethasone
Faralli JA; Clark RW; Filla MS; Peters DM
Experimental Eye Research 2014; 130: 9-16 (IGR: 16-3)

58445 Evaluation of retinal nerve fiber layer thickness in vernal keratoconjunctivitis patients under long-term topical corticosteroid therapy
Cingu AK; Cinar Y; Turkcu FM; Sahinoglu-Keskek N; Sahin A; Sahin M; Yuksel H; Caca I
Cutaneous and Ocular Toxicology 2014; 33: 184-188 (IGR: 16-3)

58902 Over-the-counter migration of steroid use: impact on the eye
Bielory B; Bielory L
Current opinion in allergy and clinical immunology 2014; 14: 471-476 (IGR: 16-3)

59314 Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep
Candia OA; Gerometta RM; Danias J
Experimental Eye Research 2014; 128: 114-116 (IGR: 16-3)

59301 Steroid treatment and risk of glaucoma
Jeppesen P; Krag S
Ugeskrift for Laeger 2014; 176: (IGR: 16-3)

58855 IMPACT ON INTRAOCULAR PRESSURE AFTER 20-MG DECANTED TRIAMCINOLONE ACETONIDE (KENALOG) INJECTION WHEN USING PROPHYLACTIC ANTIGLAUCOMA THERAPY
Barteselli G; Amini P; Ezon IC; Nezgoda JT; Cheng L; Freeman WR
Retina (Philadelphia, Pa.) 2015; 35: 75-81 (IGR: 16-3)

59117 Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit
Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
Clinical and Experimental Ophthalmology 2015; 43: 234-238 (IGR: 16-3)

58755 Periocular corticosteroid injections in uveitis: effects and complications
Sen HN; Vitale S; Gangaputra SS; Nussenblatt RB; Liesegang TL; Levy-Clarke GA; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Kempen JH
Ophthalmology 2014; 121: 2275-2286 (IGR: 16-3)

59616 Uveitis in Behçet Disease in a Tertiary Center Over 25 Years: The KKESH Uveitis Survey Study Group
Arevalo JF; Lasave AF; Al Jindan MY; Al Sabaani NA; Al-Mahmood AM; Al-Zahrani YA; Al Dhibi HA;
American Journal of Ophthalmology 2015; 159: 177-184.e2 (IGR: 16-3)

58957 Steroid-induced ocular hypertensive response in children and adolescents with acute lymphoblastic leukemia and non-Hodgkin lymphoma
de Queiroz Mendonca C; de Souza CP; Martins-Filho PR; Viana SS; Leal BC; Cipolotti R
Pediatric Blood and Cancer 2014; 61: 2083-2085 (IGR: 16-3)

57280 Dexamethasone Increases Cdc42 Expression in Human TM-1 Cells
Qiu X; Wu K; Lin X; Liu Q; Ye Y; Yu M
Current Eye Research 2014; 0: 1-10 (IGR: 16-2)

57146 Intracameral triamcinolone acetonide in glaucoma surgery: a prospective randomized controlled trial
Koval MS; Moster MR; Freidl KB; Waisbourd M; Jain SG; Ichhpujani P; Myers JS; Pro MJ
American Journal of Ophthalmology 2014; 158: 395-401.e2 (IGR: 16-2)

56532 Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma
Zode GS; Sharma AB; Lin X; Searby CC; Bugge K; Kim GH; Clark AF; Sheffield VC
Journal of Clinical Investigation 2014; 124: 1956-1965 (IGR: 16-1)

56253 Results of intravitreal triamcinolone acetonide in patients with macular edema secondary to branch retinal vein occlusion
Demir M; Oba E; Guven D; Acar Z; Cinar S
International journal of clinical pharmacy 2014; 36: 438-442 (IGR: 16-1)

56242 Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma
Jain A; Wordinger RJ; Yorio T; Clark AF
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 121-127 (IGR: 16-1)

56108 Severe intraocular pressure rise following intravitreal triamcinolone: a national survey to estimate incidence and describe case profiles
Jain S; Thompson JR; Foot B; Tatham A; Eke T
Eye 2014; 28: 399-401 (IGR: 16-1)

55669 Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion
Ozkaya A; Celik U; Alkin Z; Faiz Turan M; Yazici AT; Demirok A
ISRN ophthalmology 2013; 2013: 141279 (IGR: 15-4)

55282 Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator
Gerometta R; Kumar S; Shah S; Alvarez L; Candia O; Danias J
Investigative Ophthalmology and Visual Science 2013; 54: 7903-7909 (IGR: 15-4)

55663 Critical appraisal of loteprednol ointment, gel, and suspension in the treatment of postoperative inflammation and pain following ocular and corneal transplant surgery
Pirouzian A; Craven ER
Clinical Ophthalmology 2014; 8: 379-387 (IGR: 15-4)

55518 Atopic keratoconjunctivitis: A review
Chen JJ; Applebaum DS; Sun GS; Pflugfelder SC
Journal of the American Academy of Dermatology 2014; 70: 569-575 (IGR: 15-4)

55066 Dexamethasone induces cross-linked actin networks in trabecular meshwork cells through noncanonical wnt signaling
Yuan Y; Call MK; Zhang Y; Fischesser K; Liu CY; Kao WW
Investigative Ophthalmology and Visual Science 2013; 54: 6502-6509 (IGR: 15-4)

55465 Intractable glaucoma necessitating dexamethasone implant (Ozurdex) removal and glaucoma surgery in a child with uveitis
Kumari N; Parchand S; Kaushik S; Singh R
British Medical Journal (Clinical Research Edition) Case Reports 2013; 2013: (IGR: 15-4)

55207 Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids
Shrestha S; Thapa M; Shah DN
Ocular Immunology and Inflammation 2014; 22: 110-115 (IGR: 15-4)

54632 Is visual function affected in severe ocular allergies?
Leonardi A; Bonini S
Current opinion in allergy and clinical immunology 2013; 13: 558-562 (IGR: 15-3)

54825 Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgraduate Medicine 2013; 125: 51-58 (IGR: 15-3)

54811 Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India
Saboo US; Jain M; Reddy JC; Sangwan VS
Indian Journal of Ophthalmology 2013; 61: 486-489 (IGR: 15-3)

54715 Managing IBD outside the gut: ocular manifestations
Calvo P; Pablo L
Digestive diseases (Basel, Switzerland) 2013; 31: 229-232 (IGR: 15-3)

53915 Intraocular pressure monitoring post intravitreal steroids: a systematic review
Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
Survey of Ophthalmology 2013; 58: 291-310 (IGR: 15-2)

53984 Comparison of Dorzolamide/Timolol Versus Brimonidine/Timolol Fixed Combination Therapy in the Management of Steroid-induced Ocular Hypertension
Seymenoğlu G; Baser EF; Oztürk B; Gülhan C
Journal of Glaucoma 2015; 24: 111-116 (IGR: 15-2)

53664 Corticosteroids for ocular toxoplasmosis
Jasper S; Vedula SS; John SS; Horo S; Sepah YJ; Nguyen QD
Cochrane Database of Systematic Reviews 2013; 4: CD007417 (IGR: 15-2)

53780 Effect of intranasal budesonide irrigations on intraocular pressure
Seiberling KA; Chang DF; Nyirady J; Park F; Church CA
International forum of allergy & rhinology 2013; 3: 704-707 (IGR: 15-2)

53893 Symptoms and therapy for steroid glaucoma
Rüfer F; Uthoff D
Klinische Monatsblätter für Augenheilkunde 2013; 230: 692-696 (IGR: 15-2)

53516 Reliability and safety of intravitreal Ozurdex injections : The ZERO study
Schmitz K; Maier M; Clemens CR; Höhn F; Wachtlin J; Lehmann F; Bertelmann T; Rüdiger K; Horn M; Bezatis A; Spital G; Meyer CH;
Ophthalmologe 2014; 111: 44-52 (IGR: 15-2)

53541 Successful trabeculotomy in a patient with corticosteroid-induced glaucoma with anti-aquaporin 4 antibody-positive neuromyelitis optica: a case report
Kawamura M; Zako M
Journal of Medical Case Reports 2013; 7: 101 (IGR: 15-2)